121 related articles for article (PubMed ID: 3004707)
1. Anchorage dependency effects on difluoromethylornithine cytotoxicity in human lung carcinoma cells.
Luk GD; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1844-8. PubMed ID: 3004707
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
4. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
Seidenfeld J; Komar KA
Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
7. Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment.
Seidenfeld J; Komar KA; Naujokas MF; Block AL
Cancer Res; 1986 Mar; 46(3):1155-9. PubMed ID: 3080235
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Deen DF; Oredsson SM; Marton LJ
Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
10. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine.
Seidenfeld J; Block AL; Komar KA; Naujokas MF
Cancer Res; 1986 Jan; 46(1):47-53. PubMed ID: 3079590
[TBL] [Abstract][Full Text] [Related]
11. Differential response to treatment with the bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in culture.
Casero RA; Ervin SJ; Celano P; Baylin SB; Bergeron RJ
Cancer Res; 1989 Feb; 49(3):639-43. PubMed ID: 2535963
[TBL] [Abstract][Full Text] [Related]
12. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
13. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
15. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
Oredsson SM; Billgren M; Heby O
Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
[TBL] [Abstract][Full Text] [Related]
16. Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
Abeloff MD; Rosen ST; Luk GD; Baylin SB; Zeltzman M; Sjoerdsma A
Cancer Treat Rep; 1986 Jul; 70(7):843-5. PubMed ID: 3013400
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
Pera PJ; Kramer DL; Sufrin JR; Porter CW
Cancer Res; 1986 Mar; 46(3):1148-54. PubMed ID: 3080234
[TBL] [Abstract][Full Text] [Related]
18. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
Dorr RT; Liddil JD; Gerner EW
Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
[TBL] [Abstract][Full Text] [Related]
19. Polyamines are necessary for the survival of human small-cell lung carcinoma in culture.
Luk GD; Goodwin G; Marton LJ; Baylin SB
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2355-8. PubMed ID: 6264474
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.
Käpyaho K; Sinervirta R; Jänne J
Cancer Res; 1985 Apr; 45(4):1444-8. PubMed ID: 3919940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
